Retatrutide - Weight Loss Medication

Retatrutide is a weight management medication currently going through clinical trials. It is being developed by Eli Lilly.

This is a triple agonist, meaning it targets three hormones connected to weight loss.

The medication focuses on:

• GLP-1
• GIP
• Glucagon

Retatrutide is currently not available, but as soon as clinical trials are complete and the medicaiton is licenced it will be available through Shape8.